|
Real-time Estimate
Cboe BZX
15:42:31 06/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 36.64 USD | -1.56% |
|
-13.27% | +12.47% |
| 10-01 | Truist Cuts Price Target on Axogen to $53 From $60, Keeps Buy Rating | MT |
| 09-30 | Axogen, Inc. completed its acquisition of BioCircuit Technologies, Inc. | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AXGN | Delayed | |
CBOE
| AXGN | Real-time | |
|
Mexican S.E.
| AXGN * | End-of-day quote | |
|
Börse Stuttgart
| LT3 | Delayed | |
|
Tradegate
| LT3 | Real-time | |
|
Deutsche Boerse AG
| LT3 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 43.39 | 51.73 | 51.47 |
| Spread/Res. | -15.16% | -28.84% | -28.48% |
| Spread/Supp. | +2.56% | +18.78% | +4.28% |
| Support | 35.89 | 30.99 | 35.3 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AXGN Stock
- Charts Axogen, Inc.
Select your edition
All financial news and data tailored to specific country editions
